Pictet Asset Management Sa Cyma Bay Therapeutics, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Cyma Bay Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 10,641 shares of CBAY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,641
Previous 15,707
32.25%
Holding current value
$0
Previous $136,000
14.71%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CBAY
# of Institutions
6Shares Held
1.82MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iii, LLC Larkspur, CA1.64MShares$015.17% of portfolio
-
Abingworth LLP London, X0131KShares$00.27% of portfolio
-
Connacht Asset Management LP New York, NY12KShares$01.09% of portfolio
-
Ctc Capital Management, LLC10.7KShares$00.2% of portfolio
-
First Republic Investment Management, Inc. San Francisco, CA10.6KShares$00.0% of portfolio
About CymaBay Therapeutics, Inc.
- Ticker CBAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,677,904
- Description
- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...